Show simple item record

FieldValueLanguage
dc.contributor.authorBell, Katy J.L.
dc.contributor.authorDoust, Jenny
dc.contributor.authorGlasziou, Paul
dc.date.accessioned2021-02-18T23:48:33Z
dc.date.available2021-02-18T23:48:33Z
dc.date.issued2018en_AU
dc.identifier.urihttps://hdl.handle.net/2123/24537
dc.description.abstractThe recent recommendations from the American College of Cardiology and the American Heart Association (ACC/AHA) to lower the thresholds for defining hypertension and for treating higher-risk patients1 have been controversial. For example, the Clinical Guidelines Committee of the American College of Physicians (ACP) argued that the changes are “not supported by evidence and may result in low-value care,” and the American Academy for Family Physicians (AAFP) raised concerns that the “harms of treating a patient to a lower blood pressure (BP) were not assessed.” The Table summarizes key differences between the ACC/AHA guideline and prior guidelines.en_AU
dc.language.isoenen_AU
dc.publisherAmerican Medical Associationen_AU
dc.relation.ispartofJAMA Internal Medicineen_AU
dc.rightsCopyright All Rights Reserveden_AU
dc.subjectblood pressureen_AU
dc.subjecthypertensionen_AU
dc.subjectguidelinesen_AU
dc.titleIncremental benefits and harms of the 2017 American College of Cardiology/American Heart Association high blood pressure guideline.en_AU
dc.typeArticleen_AU
dc.subject.asrc1102 Cardiorespiratory Medicine and Haematologyen_AU
dc.subject.asrc1117 Public Health and Health Servicesen_AU
dc.identifier.doi10.1001/jamainternmed.2018.0310
dc.relation.nhmrc527500
dc.relation.nhmrc1104136
usyd.facultySeS faculties schools::Faculty of Medicine and Health::Sydney School of Public Healthen_AU
usyd.citation.volume178en_AU
usyd.citation.issue6en_AU
usyd.citation.spage755en_AU
usyd.citation.epage757en_AU
workflow.metadata.onlyNoen_AU


Show simple item record

Associated file/s

There are no files associated with this item.

Associated collections

Show simple item record

There are no previous versions of the item available.